Wegovy is administered as a once-weekly subcutaneous injection, typically in the abdomen, thigh, or upper arm
Longer gaps in your GLP-1 treatment need careful consideration and specific recommendations from your provider
The growing popularity of GLP-1 receptor agonistsincluding Ozempic and Wegovy from Novo Nordisk, and Mounjaro and Zepbound from Eli Lillyhas added fuel to an already fiery debate over the governments role in subsidizing access to these drugs
For best results, pair with Pendulum Akkermansia
In the STEP 1 trial, 86% of participants lost at least 5% of their body weight, and 50% lost 15% or more
In one study on rat models, cytokine therapy designed to promote angiogenesis and stimulate endothelial growth was proven to effectively treat ED